|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The effect of acute oxidative stress on the ultrastructure of the perfused rat liver 显示文摘 | Cogger V C Mross P E Hosie M J | 2001 | Pharmacol Toxicol2001，89，6： | 1 |
| 2 | Phase Ⅰ clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours 显示文摘 | Mross K Drevs J Muller M | 2005 | Eur J Cancer2005，41，9： | 1 |
| 3 | Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion 显示文摘 | RASSMANN I THODTMANN R MROSS M | 1998 | Invest New Drugs1998，16，4： | 1 |
| 4 | Phase Ⅰ clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor,in patients with liver metasta- ses from solid tumors显示文摘 | Mross K Drevs J Muller M Medinger M Marine D Hennig J | 2005 | Eur J Cancer2005，41，9： | 1 |
| 5 | Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion 显示文摘 | Rassmann I Th0dtmann R Mross M | 1998 | Invest New Drugs1998，16，4： | 1 |
| 6 | Phase I study of the angiogenesis inhibitor BIBF1 120 in patients with advanced solid tumors显示文摘 | Mross K Stefanic M Gmehling D | 2010 | Clin Cancer Res2010，16，1： | 1 |
| 7 | A phase I dose-escalation study of BI 811283,an Aurora B inhibitor, administered every three weeks in patients with advanced solid tumors 显示文摘 | MROSS K B SCHEULEN M E FROST A | 2010 | J Clin Oncol2010，28，15： | 1 |
| 8 | A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered day 1 and 15, every four weeks in patients with advanced solid tumors 显示文摘 | SCHEULEN M E MROSS K B RICHLY H | 2010 | J Clin Oncol2010，28，15： | 1 |
| 9 | Phase I clinical and pharmacokinetic study of PrrK/ZK,a muhiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours 显示文摘 | Mross K Drevs J Muller M | 2005 | Eor J Cancer2005，41，9： | 1 |
| 10 | A phase I A, open - label, dose - escalating study of PTK787/ZK222584 administered orally on a continuous dosing schedule in patients with advanced cancer显示文摘 | DREVS J MEDINGER M MROSS K | 2010 | Anticancer Res2010，30，6： | 1 |
| 11 | Phase I clinical and pharmacokinetic study of PTK/ZK,a multiple VEGF receptor inhibitor,in patients with liver metastases from solid tumours显示文摘 | Mross K Drevs J Muller M | 2005 | Eur J Cancer2005，41，9： | 1 |
| 12 | Clinical trials with anti-angiogenic agents in hematological malignancies显示文摘 | Medinger M Mross K | 2010 | J Angiogenes Res2010，2，： | 1 |
| 13 | Phase Ⅰ clinical evaluation of AZD2171,a highly potent VEGF receptor tyrosine kinase inhibitor,in patients with advanced tumors显示文摘 | DREVS J MEDINGER M MROSS K | 2005 | J Clin Oncol2005，，19： | 1 |
| 14 | Phase Ⅰ clinical and pharmacokinetic study of PTK/ZK,a multiple VEGF receptor inhibitor,in patients with liver metastases from solid tumours显示文摘 | Mross K Drevs J Muller M | 2005 | Eur J Cancer2005，41，9： | 1 |
| 15 | Phase Ⅰ clinical and pharmacokinetic study of PTK/ZK,a multiple VEGF receptor inhibitor,in patients with liver metastases from solid tumours显示文摘 | Mross K Drevs J Muller M | 2005 | Eur J Cancer2005，41，9： | 1 |
| 16 | Adjuvant and palliative anticancer treatment of colon carcinoma in 2004 显示文摘 | Medinger M Steinbild S Mross K | 2004 | Schweiz Rundsch Med Prax2004，93，40： | 1 |
| 17 | Adjuvant and palliativeanticancer treatment of colon carcinoma in 2004 显示文摘 | Medinger M Steinbild S Mross K | 2004 | Praxis (Bern1994)2004，93，40： | 1 |
| 18 | Phase II trial of dexverapamil and epirubicin in patients with non responsive metastatic breast cancer显示文摘 | Mross K Schueller J | 1998 | Br J Cancer1998，77，： | 1 |
| 19 | Phase I clinical and pharmacokinetic study of PTILCZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumors 显示文摘 | MROSS K DREVS J MULLER M | 2005 | Eur J Canaer2005，41，9： | 1 |
| 20 | Phase Ⅰ clinical and pharmacokinetic study of PTK/ZK,a multiple VEGF receptor inhibitor,in patients with liver metastasee from solid tumours显示文摘 | MROSS K DREVS J MULLER M | 2005 | Eur J Cancer2005，41，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员